Probi AB (PROB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies –... Research Beam Model: Research Beam Product ID: 1724972 125 USD New
Probi AB (PROB) - Financial and Strategic SWOT Analysis Review
 
 

Probi AB (PROB) - Financial and Strategic SWOT Analysis Review

  • Category : Company Profiles
  • Published On : July   2017
  • Pages : 43
  • Publisher : GlobalData
 
 
 
Probi AB (PROB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Probi AB (Probi) is a biotechnology company which develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improving gastrointestinal health and the immune system. It distributes its products to leading food, health-product and pharmaceutical companies in the functional food and consumer healthcare segments. Probi markets its products through four different platforms: Probi Premium, Probi Select, Probi LiveBac and Probi Bio-tract. The company has operational presence in Sweden, Rest of Europe, North America and Rest of world. Probi is headquartered in Lund, Sweden.

Probi AB Key Recent Developments

May 04,2017: Probi continues on its successful growth path
Feb 14,2017: Probi appoints Jorn Andreas as new CFO
Jan 10,2017: Probi - Strong Growth in net Sales and Operating Profit in the Fourth Quarter
Apr 27,2016: Probi: Q1 2016: Highest Net Sales To Date For A Single Quarter: MSEK 87.0 (68.9)
Jan 26,2016: Probi Announced Q4 Results For Full-Year 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Probi AB - Key Facts 5
Probi AB - Key Employees 6
Probi AB - Key Employee Biographies 7
Probi AB - Major Products and Services 8
Probi AB - History 9
Probi AB - Company Statement 12
Probi AB - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Probi AB - Business Description 14
Probi AB - SWOT Analysis 15
SWOT Analysis - Overview 15
Probi AB - Strengths 15
Probi AB - Weaknesses 16
Probi AB - Opportunities 17
Probi AB - Threats 18
Probi AB - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Probi AB, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Probi AB, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
May 04, 2017: Probi continues on its successful growth path 30
Feb 14, 2017: Probi appoints Jorn Andreas as new CFO 34
Jan 10, 2017: Probi - Strong Growth in net Sales and Operating Profit in the Fourth Quarter 35
Apr 27, 2016: Probi: Q1 2016: Highest Net Sales To Date For A Single Quarter: MSEK 87.0 (68.9) 36
Jan 26, 2016: Probi Announced Q4 Results For Full-Year 2015 37
Jan 26, 2016: Probi: Q4 2015 - 60% Growth and Increased Operating Margin for Full-Year 2015 38
Section 6 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Probi AB, Key Facts 5
Probi AB, Key Employees 6
Probi AB, Key Employee Biographies 7
Probi AB, Major Products and Services 8
Probi AB, History 9
Probi AB, Subsidiaries 13
Probi AB, Key Competitors 19
Probi AB, Ratios based on current share price 20
Probi AB, Annual Ratios 21
Probi AB, Annual Ratios (Cont...1) 22
Probi AB, Annual Ratios (Cont...2) 23
Probi AB, Interim Ratios 25
Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Probi AB, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Probi AB, Recent Deals Summary 29
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter